Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$27.23 - $45.56 $7.24 Million - $12.1 Million
-265,819 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$27.75 - $40.17 $948,522 - $1.37 Million
-34,181 Reduced 11.39%
265,819 $9.93 Million
Q1 2018

May 14, 2018

SELL
$28.83 - $41.01 $4.32 Million - $6.15 Million
-150,000 Reduced 33.33%
300,000 $8.87 Million
Q4 2017

Feb 13, 2018

BUY
$28.45 - $37.14 $5.69 Million - $7.43 Million
200,000 Added 80.0%
450,000 $15.5 Million
Q3 2017

Nov 13, 2017

BUY
$24.01 - $36.2 $6 Million - $9.05 Million
250,000
250,000 $9.08 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.